Diagnosis Ibex Granted FDA Breakthrough Device Designation AIT News Desk Jun 9, 2021 Ibex’s Galen™ AI-powered platform is recognized by the FDA as breakthrough technology with the potential to more effectively diagnose cancer Ibex…
Diagnosis Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth AIT News Desk Jun 2, 2021 Fueling growth by enabling IVD test development and manufacturing, deepening scientific capabilities and expanding cancer diagnostics scope to 8 of…
Life Sciences Ibex Medical Analytics Raises $38 Million to Accelerate Adoption of AI-Powered Cancer Diagnostics in… AIT News Desk Mar 9, 2021 Ibex’s AI technology helps physicians and providers diagnose cancer with greater real-time accuracy by reducing error and misdiagnosis Ibex…
Diagnosis AI Cancer Diagnostics Leader Ibex Medical Analytics Expands to the Americas With Appointment of Joel… AIT News Desk Jan 8, 2021 Digital Pathology Industry Veteran, Joel Duckworth Will Lead Ibex Medical Analytics Growth in the Americas as Chief Revenue Officer Ibex…
Diagnosis Ibex Medical Analytics, the Leader in AI-Powered Based Cancer Diagnostics, Is Now ISO 13485… AIT News Desk Nov 5, 2020 The ISO 13485 certification validates Ibex Medical Analytics' position as a leading and quality-focused solution provider for healthcare organizations…
Diagnosis Visiopharm Announces Scientific Advisory Board AIT News Desk Oct 6, 2020 Visiopharm, the Denmark-based leader in artificial intelligence-driven image analysis, tissue mining, and precision pathology has announced the…
Life Sciences Cancer Diagnostics in France as Ibex Medical Analytics Deploys Its AI-Based Technology for Pathology… AIT News Desk Jul 21, 2020 Ibex’s Galen Prostate solution is now used in routine clinical practice at France’s largest network of pathology labs, helping pathologists improve…